These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 19450980)
21. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1. Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288 [TBL] [Abstract][Full Text] [Related]
22. N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275. Siu M; Johnson TO; Wang Y; Nair SK; Taylor WD; Cripps SJ; Matthews JJ; Edwards MP; Pauly TA; Ermolieff J; Castro A; Hosea NA; LaPaglia A; Fanjul AN; Vogel JE Bioorg Med Chem Lett; 2009 Jul; 19(13):3493-7. PubMed ID: 19473839 [TBL] [Abstract][Full Text] [Related]
23. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening. Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088 [TBL] [Abstract][Full Text] [Related]
24. Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors. Shah U; Boyle CD; Chackalamannil S; Baker H; Kowalski T; Lee J; Terracina G; Zhang L Bioorg Med Chem Lett; 2010 Mar; 20(5):1551-4. PubMed ID: 20149650 [TBL] [Abstract][Full Text] [Related]
25. Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Su X; Vicker N; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV Mol Cell Endocrinol; 2006 Mar; 248(1-2):214-7. PubMed ID: 16325333 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Ye XY; Chen SY; Nayeem A; Golla R; Seethala R; Wang M; Harper T; Sleczka BG; Li YX; He B; Kirby M; Gordon DA; Robl JA Bioorg Med Chem Lett; 2011 Nov; 21(22):6699-704. PubMed ID: 21983439 [TBL] [Abstract][Full Text] [Related]
27. Distinctive molecular inhibition mechanisms for selective inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Tu H; Powers JP; Liu J; Ursu S; Sudom A; Yan X; Xu H; Meininger D; Degraffenreid M; He X; Jaen JC; Sun D; Labelle M; Yamamoto H; Shan B; Walker NP; Wang Z Bioorg Med Chem; 2008 Oct; 16(19):8922-31. PubMed ID: 18789704 [TBL] [Abstract][Full Text] [Related]
28. Diazepane-acetamide derivatives as selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors. Odermatt A Expert Opin Ther Pat; 2009 Oct; 19(10):1477-83. PubMed ID: 19780703 [TBL] [Abstract][Full Text] [Related]
29. Docking-based 3D-QSAR study for 11beta-HSD1 inhibitors. Lee JH; Kang NS; Yoo SE Bioorg Med Chem Lett; 2008 Apr; 18(7):2479-90. PubMed ID: 18314331 [TBL] [Abstract][Full Text] [Related]
30. Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model. Julian LD; Wang Z; Bostick T; Caille S; Choi R; DeGraffenreid M; Di Y; He X; Hungate RW; Jaen JC; Liu J; Monshouwer M; McMinn D; Rew Y; Sudom A; Sun D; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP J Med Chem; 2008 Jul; 51(13):3953-60. PubMed ID: 18553955 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and structural activity relationship of 11beta-HSD1 inhibitors with novel adamantane replacements. Yeh VS; Kurukulasuriya R; Madar D; Patel JR; Fung S; Monzon K; Chiou W; Wang J; Jacobson P; Sham HL; Link JT Bioorg Med Chem Lett; 2006 Oct; 16(20):5408-13. PubMed ID: 16890427 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and SAR of piperidyl-oxadiazoles as 11β-hydroxysteroid dehydrogenase 1 inhibitors. Xia G; You X; Liu L; Liu H; Wang J; Shi Y; Li P; Xiong B; Liu X; Shen J Eur J Med Chem; 2013 Apr; 62():1-10. PubMed ID: 23353742 [TBL] [Abstract][Full Text] [Related]
33. Recent advances in the discovery of 11beta-HSD1 inhibitors. Boyle CD Curr Opin Drug Discov Devel; 2008 Jul; 11(4):495-511. PubMed ID: 18600567 [TBL] [Abstract][Full Text] [Related]
34. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors. Cho YS; Kim CH; Cheon HG Anal Biochem; 2009 Sep; 392(2):110-6. PubMed ID: 19497289 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and 11β hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group. Kwon SW; Kang SK; Lee JH; Bok JH; Kim CH; Dal Rhee S; Jung WH; Kim HY; Bae MA; Song JS; Ha DC; Cheon HG; Kim KY; Ahn JH Bioorg Med Chem Lett; 2011 Jan; 21(1):435-9. PubMed ID: 21093259 [TBL] [Abstract][Full Text] [Related]
36. Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1). Wu SC; Yoon D; Chin J; van Kirk K; Seethala R; Golla R; He B; Harrity T; Kunselman LK; Morgan NN; Ponticiello RP; Taylor JR; Zebo R; Harper TW; Li W; Wang M; Zhang L; Sleczka BG; Nayeem A; Sheriff S; Camac DM; Morin PE; Everlof JG; Li YX; Ferraro CA; Kieltyka K; Shou W; Vath MB; Zvyaga TA; Gordon DA; Robl JA Bioorg Med Chem Lett; 2011 Nov; 21(22):6693-8. PubMed ID: 21983444 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors. Yeh VS; Patel JR; Yong H; Kurukulasuriya R; Fung S; Monzon K; Chiou W; Wang J; Stolarik D; Imade H; Beno D; Brune M; Jacobson P; Sham H; Link JT Bioorg Med Chem Lett; 2006 Oct; 16(20):5414-9. PubMed ID: 16899366 [TBL] [Abstract][Full Text] [Related]
38. Pyrrolidine-pyrazole ureas as potent and selective inhibitors of 11β-hydroxysteroid-dehydrogenase type 1. Venier O; Pascal C; Braun A; Namane C; Mougenot P; Crespin O; Pacquet F; Mougenot C; Monseau C; Onofri B; Dadji-Faïhun R; Leger C; Ben-Hassine M; Van-Pham T; Ragot JL; Philippo C; Güssregen S; Engel C; Farjot G; Noah L; Maniani K; Nicolaï E Bioorg Med Chem Lett; 2011 Apr; 21(8):2244-51. PubMed ID: 21439819 [TBL] [Abstract][Full Text] [Related]